COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary
MMW Fortschritte der Medizin 143(42): 64
2001
ISSN/ISBN: 1438-3276 PMID: 11697296 Document Number: 529586
Document emailed within 1 workday
Related Documents
Buch, H.J. 1970: Treatment of arthrosis with protease-inhibitor Contrykal Das Deutsche Gesundheitswesen 25(20): 947-950Martin-Carbonero, L. 2004: Discontinuation of the clinical development of fusion inhibitor T-1249 Aids Reviews 6(1): 61
Rémy, A.; Avouac, J.; Gossec, L.; Combe, B. 2011: Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis Clinical and Experimental Rheumatology 29(1): 96-103
Lodewijckx, E. 1987: La perception des contraceptifs et quelques données sur la discontinuation - Attitudes towards contraception and some reasons for discontinuation Contraception Fertilite Sexualite (1973) 15(11): 1025-1030
Laurell, M.; Stenflo, J. 1989: Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thrombosis and Haemostasis 62(3): 885-891
Milazzo, F.; Paino, R.; Visigalli, M.M.; Belloli, F.; Merli, M. 1999: Coagulation in heart transplant operations and in operations for applying ventricular assistance devices Minerva Anestesiologica 65(1-2 Suppl 1: 93-104
Hughey, M.J.; McElin, T.W.; Lussky, R. 1978: Forceps operations in perspective. I. Midforceps rotation operations Journal of Reproductive Medicine 20(5): 253-259
Khan, N.A.; Havouis, R.; Quemener, V.; Moulinoux, J.P. 1992: Protein kinase C inhibitor (H-7) potentiates antiproliferative effects of a polyamine biosynthesis inhibitor Anticancer Research 12(4): 1223-1226
Depré, M.; Van Hecken, A.; Verbesselt, R.; De Lepeleire, I.; Schwartz, J.; Porras, A.; Larson, P.; Lin, C.; De Schepper, P.J. 1998: Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man International Journal of Clinical Pharmacology Research 18(2): 53-61
Humphreys, W.V.; Byrne, J.; James, W. 2000: Elective abdominal aortic aneurysm operations--the results of a single surgeon series of 243 consecutive operations from a district general hospital Annals of the Royal College of Surgeons of England 82(1): 64-68
Bolten, W.W. 2003: In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor MMW Fortschritte der Medizin 145(5): 9
Traber, D.L.; Adams, T.; Sziebert, L.; Williams, P.; Traber, L.D. 1984: Failure of a protease inhibitor to affect the cardiopulmonary response to endotoxin when combined with a cyclooxygenase inhibitor Circulatory Shock 13(4): 319-323
Tourbaf, K.D.; Dunlap, B.E.; Ambrus, J.L.; Rodman, D.J.; Atwal, A.J. 1982: The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia a patient with inhibitor Journal of Medicine 13(5-6): 399-410
Błach-Olszewska, Z.; Wrześniowska, U. 1986: Inhibitor of physiological interferon synthesis. I. Isolation, physiochemical and biological properties of crude inhibitor preparations Archivum Immunologiae et Therapiae Experimentalis 34(5-6): 533-540
Sills, T.; Heptinstall, S. 1986: Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour Thrombosis and Haemostasis 55(3): 305-308
Kakinuma, Y.; Miyauchi, T. 2001: Endothelin receptor antagonist, phosphodiesterase inhibitor, thromboxane inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 59(6): 1139-1144
Tamura, M.; Konishi, F.; Inagami, T. 1993: A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands Journal of Cardiovascular Pharmacology 22(Suppl 2): S47-S50
Due, C.; Ebbesen, P. 1981: Mouse skin beta-irradiated 3 months earlier shows increased content of a 30-50,000 MW mitotic inhibitor and decreased susceptibility to an exogenous inhibitor Anticancer Research 1(2): 87-88
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816
Soszka, T.; Piszka, J.; Falkowska, K.; Falkowski, B.; Lukasiak, T. 1989: Dynamic assessment of hemostasis after gynecological operations. I. Effect of gynecological operations on hemostatic function Ginekologia Polska 60(6): 306-313